Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-20-000155

Chief Financial Officer gave up 42,262 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

File Justin J. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-05-22 Shares withheld for taxes : show line 1 in the form −42,262 $4.99 $210,887 280,415 D
Loading xslF345X03/wf-form4_159052772480668.xml…